Yale Study Proposed Policy Changes to Cut Health Costs
New research suggests 23 policy shifts that could reduce national health care spending by $450 billion annually.
Updated on Oct. 12, 2026 in Healthcare
Live Poll
Should the government prioritize targeted cost-saving policy changes over a major overhaul of the healthcare system?
Researchers have identified 23 policy changes aimed at curbing the $5 trillion U.S. health care system. These recommendations target hospital consolidation and drug pricing to mitigate the rising insurance premiums that have plagued the industry.
Why it matters
Rising costs are increasingly passed to businesses through private insurance premiums, with health care spending accounting for 91% of these increases between 2011 and 2024. These policy shifts aim to address systemic inefficiencies that drive pricing upward.
The 1% Steps project proposes 23 policy changes to address a $5 trillion annual system cost, targeting an estimated $450 billion in annual savings. These measures respond to a period where health care spending growth drove 91% of private insurance premium hikes.
The players
Yale University
An academic institution that researches health policy and economic impacts of industry consolidation.
The details
The project analyzes how hospital consolidation leads to price disparities, specifically noting that Medicare pays higher rates for services in hospital-owned practices compared to independent ones. It further targets drug pricing by addressing pay-for-delay patent practices. These changes are designed to encourage market competition and lower costs, noting that generic drugs typically retail for 70% to 80% less than brand-name counterparts within one year of market entry.
Timeline
2011 to 2024: Growth in health care spending drove 91% of private insurance premium increases.
Past 25 years: Hospital prices increased faster than other economic sectors.
Market Landscape
The study provides a policy framework to reform the Medicare Physician Fee Schedule hospital-outpatient payment disparity, which currently incentivizes hospital acquisition of independent practices. This effort aligns with broader legislative trends aimed at curbing consolidation-driven cost increases.
Operators should monitor future legislative discussions regarding hospital billing parity and generic drug patent laws as potential indicators of future insurance premium relief. Tracking these policy shifts is essential for managing long-term employee health benefit costs.
The takeaway
The research highlights how systemic consolidation and drug pricing practices directly inflate employer health insurance costs. Business owners should review their current health plan structures and monitor upcoming federal policy proposals for potential shifts in provider reimbursement rules.
Further reading
For more analysis on current industry trends, visit the Healthcare section.
Source note: This article includes information reported by Connecticut Public.
Live Poll
Should the government prioritize targeted cost-saving policy changes over a major overhaul of the healthcare system?
